Target intelligence / Profile preview

C5a peptidase of Streptococcus pyogenes (ScpA)

Target
ScpA
Molecular classification
Enzyme, Protease, Cell surface-associated endopeptidase, Adhesin, Invasin
01

Overview

C5a peptidase (ScpA) of Streptococcus pyogenes is a highly specific, cell-surface endopeptidase and virulence factor that cleaves the His-Lys bond in the complement component C5a, thereby inactivating its chemotactic and pro-inflammatory functions and blunting neutrophil recruitment to sites of infection. ScpA is also capable of cleaving C3 and C3a, expanding its role in disarming complement-driven host defense. Structurally, ScpA is a multidomain enzyme with a signal peptide, an N-terminal subtilisin-like protease domain, fibronectin type III domains, and cell wall anchoring features; it is expressed on the bacterial surface and functions both enzymatically and as an adhesin/invasin for host interactions. Antibodies targeting ScpA can neutralize its function and have shown protection in animal models, making ScpA a promising candidate for vaccine development against group A streptococcal diseases.

Other names
Streptococcal C5a peptidaseScpASCPAC5a-inactivating enzyme
02

Mechanism of action

Proteolysis of C5a (and C3, C3a) to reduce neutrophil chemotaxis and impair host immune response (Targeting the enzyme, e.g., by vaccination, elicits neutralizing antibodies that block this function, restoring immune recruitment to the site of infection)

03

Biological functions

Immune evasionProteolytic inactivation of complement factor C5aProteolytic inactivation of complement factors C3 and C3aAdhesion to host cells (epithelial, endothelial)Invasion of host tissue
04

Disease associations

Infection (specifically, pathogenesis and immune evasion in Streptococcus pyogenes group A streptococcal infections)Other (virulence in invasive and non-invasive streptococcal disease; can influence dissemination and severity in human infections)
05

Safety considerations

Potential for autoimmunity or overactivation of the immune response if targeted therapeutically, as C5a peptidase modulates powerful inflammatory mediators of the complement pathwayCross-reactivity concerns in vaccine design, though studies to date report high immunogenicity and protective responses in animal models without notable safety issues
06

Interacting drugs

None approved or in clinical use currently. Some investigational vaccines and inhibitory antibodies have targeted C5a peptidase for preclinical vaccine strategies, but there are no approved pharmacologic inhibitors in clinical practice
07

Biomarkers

Antibodies to ScpA (may reflect prior infection or vaccine response)ScpA expression level (in bacteria, could correlate with virulence in infection)

Beyond the preview

Go deeper on C5a peptidase of Streptococcus pyogenes (ScpA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on C5a peptidase of Streptococcus pyogenes (ScpA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call